The U.S. spent $325 billion on prescription drugs in 2012.1 Though spending has leveled off in recent years thanks to the availability of many generic medications, spending is soon expected to jump, in large part because of the increase in specialty drugs.2 These complex medications, often made from living organisms, treat serious diseases — some that were formerly untreatable. But these drugs often come with a seriously high price tag. Four specialty drugs approved by the FDA in 2012 cost $200,000 or more per patient a year.3 Some experts believe that specialty medications will make up 45 percent of drug manufacturers’ sales by 2017.4 These high-priced drugs contribute to rising medical costs.